Sudarshan Sukhani of s2analytics.com is upbeat on Dr Reddys Lab.
Sukhani told CNBC-TV18, “I would be very upbeat on Dr Reddys. I will just ignore whatever the fundamentals are, good or bad, I wouldn’t understand it. Pharma is the second sector where short selling is not advised, where you have to be a buyer on dips.”
He further added, “All the stocks are either the best stocks, either making like new highs, making bullish patterns or on the verge of making these breakouts. So Dr Reddy’s is a buying opportunity, not necessarily today or certainly in the next couple of days.”
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!